CHEK
Check-Cap Ltd. [CHEK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CHEK Stock Summary
In the News
CHEK Financial details
Company Rating
-
Market Cap
13.22M
Income
-17.65M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
85
Optionable
No
Shortable
Yes
Earnings
12 Apr 2024
P/E
-0.7
Forward P/E
-
PEG
0.26
P/S
-
P/B
0.45
P/C
-
P/FCF
-0.7
Quick Ratio
17.17
Current Ratio
17.6
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-3.02
EPS next Y
-
EPS next Q
-
EPS this Y
-17.92%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-62.71%
-
-
-
-
SMA20
6.1%
SMA50
-21.97%
SMA100
128.95%
Inst Own
-
Inst Trans
-
ROA
-61%
ROE
-52%
ROC
-0.71%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.27-4.625
52W High
-57%
52W Low
+72%
RSI
52.02
Rel Volume
0.26
Avg Volume
264.2K
Volume
67.78K
Perf Week
-1.71%
Perf Month
23.74%
Perf Quarter
123.38%
Perf Half Y
129.33%
-
-
-
-
Beta
0.123
-
-
Volatility
0.05%, 0.19%
Prev Close
0%
Price
1.72
Change
-3.91%
Company Profile
- Volume Average 264.2K
- Market Capitalization 13.22M
- Employee 85
- CEO Mr. Alex Ovadia
- Headquarters Isfiya,IL
- IPO Date 2015-03-04
-
Website
https://www.check-cap.com 
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
